Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | A-1210477 | Mcl-1 | Misc | Inf | 0.9419 | -0.0065 | -0.0001 | 0.0000 | Inf | 0.41975 |
Hs 578T | Olaparib | PARP | Misc | 8.9082 | 0.4435 | 0.0997 | 0.0101 | 1.0369 | 25.6993 | 0.93656 |
Hs 578T | Bleomycin | Radiation | Misc | 0.25197 | -0.1966 | 0.4462 | 0.2094 | 0.9580 | 0.37819 | 0.99872 |
Hs 578T | Ipatasertib | AKT | PI3K/mTOR | 4.5924 | 0.4423 | 0.2458 | 0.0093 | 0.5006 | 0.34659 | 0.98155 |
Hs 578T | Alpelisib | PI3Ka | PI3K/mTOR | 11.8954 | 0.5308 | 0.0905 | 0.0063 | 0.7199 | 54.7171 | 0.9693 |
Hs 578T | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.57529 | -0.0179 | 0.3736 | 0.0734 | 0.3919 | 8.8945 | 0.98886 |
Hs 578T | TGX221 | PI3Kb | PI3K/mTOR | 34.4921 | 0.7094 | 0.0668 | 0.0103 | 0.5623 | 243.351 | 0.9333 |
Hs 578T | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0070774 | -0.2174 | 0.5683 | 0.1373 | 0.7608 | 0.010409 | 0.98427 |
Hs 578T | Everolimus | mTOR1 | PI3K/mTOR | 0.0056053 | 0.4204 | 0.5273 | 0.0278 | 0.4084 | 2.87e-05 | 0.64462 |
Hs 578T | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0090588 | -0.0708 | 0.6226 | 0.1010 | 1.2366 | 0.0087974 | 0.98428 |
Hs 578T | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.9143 | 0.0252 | 0.0005 | 2.0096 | 0.1778 | 0.76824 |
Hs 578T | Buparlisib | pan PI3K | PI3K/mTOR | 0.68631 | -0.3434 | 0.3760 | 0.1520 | 1.4596 | 1.0562 | 0.9918 |
Hs 578T | Pictilisib | pan PI3K | PI3K/mTOR | 1.1555 | 0.0345 | 0.3109 | 0.0488 | 0.4397 | 14.0561 | 0.97858 |
Hs 578T | Ceritinib | ALK | RTK | 0.96543 | -0.4356 | 0.3052 | 0.1254 | 0.8330 | 3.6097 | 0.98175 |
Hs 578T | Neratinib | EGFR/HER2 | RTK | 0.6444 | -0.1608 | 0.2025 | 0.0665 | 0.8744 | 2.2637 | 0.98743 |
Hs 578T | Tivantinib | MET | RTK | 0.33668 | -0.3204 | 0.4411 | 0.2071 | 2.0560 | 0.42597 | 0.99878 |
Hs 578T | Cediranib | VEGFR/cKIT | RTK | 0.55083 | -0.5723 | 0.3937 | 0.1358 | 0.6641 | 2.8803 | 0.96002 |
Hs 578T | Cabozantinib | VEGFR2/MET | RTK | 6.3728 | 0.2155 | 0.1335 | 0.0452 | 1.3885 | 14.0588 | 0.89112 |
MCF 10A | Abemaciclib | CDK4/6 | Cell cycle | 0.34027 | 0.1513 | 0.3811 | -0.0012 | 0.5714 | 0.28176 | 0.99756 |
MCF 10A | Palbociclib | CDK4/6 | Cell cycle | 1.9503 | 0.4544 | 0.1883 | -0.0047 | 0.6492 | 0.23713 | 0.99244 |
MCF 10A | AZD7762 | CHK1/2 | Cell cycle | 1.8064 | -0.1800 | 0.2246 | 0.0802 | 0.8472 | 6.6065 | 0.99793 |
MCF 10A | Volasertib | PLK | Cell cycle | 0.022128 | -0.0887 | 0.4466 | 0.1711 | 3.5358 | 0.023168 | 0.99997 |
MCF 10A | Dinaciclib | pan CDK | Cell cycle | 0.016244 | -0.2300 | 0.5279 | 0.2344 | 5.0000 | 0.017523 | 0.99904 |
MCF 10A | Cisplatin | Chemo | Chemotherapy | 4.2937 | 0.3794 | 0.0952 | 0.0149 | 2.1287 | 2.4561 | 0.99519 |
MCF 10A | Doxorubicin | Chemo | Chemotherapy | 0.010766 | -0.3242 | 0.6549 | 0.1054 | 1.4229 | 0.012388 | 0.96407 |